Accurate detection of liabilities to de-risk antibody development
Introducing New Antibody Property Prediction Tools
Accurate detection of liabilities to de-risk antibody development
Clonal hit expansion by mining antibodies in large NGS repertoires
Developability Predictions for Antibody Engineering and Risk Mitigation | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Identify CDRs and sequence-based liablities
The Therapeutic Antibody Profiler (TAP): Five Computational Developability Guidelines
Specialized Antibody Characterization - Curia Global
Harnessing the rabbit antibody repertoire - Fusion Antibodies
Antibody Sequence Liabilities – Geneious Biologics Support
Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy - ScienceDirect
In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies | SpringerLink
Orion Antibody Discovery Suite - AbXtract
Development issues: antibody stability, developability, immunogenicity, and comparability - ScienceDirect
Accurate detection of liabilities to de-risk antibody development
Five computational developability guidelines for therapeutic antibody profiling | PNAS
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
Antibodies | Free Full-Text | Antibody Aggregation: Insights from Sequence and Structure
Frequency of liability motifs in all CDRs. Circles show percentages of... | Download Scientific Diagram
Frontiers | Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Align and Prioritize your Antibody Sequences
Samuel Schmitz – Vanderbilt Program for Next Generation Vaccines – Integrating Structural Biology with Big Data
Computational antibody methods schematic. (A) Antibody modelling... | Download Scientific Diagram
